The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria-Reference-Cited by-同舟云学术

The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria

Published:2017-11-15 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Christiansen Stig Hill,Murphy Ronan A.^ORCID,Juul-Madsen Kristian,Fredborg Marlene,Hvam Michael Lykke,Axelgaard Esben,Skovdal Sandra M.,Meyer Rikke Louise^ORCID,Sørensen Uffe B. Skov,Möller Arne,Nyengaard Jens Randel,Nørskov-Lauritsen Niels,Wang Mikala,Gadjeva Mihaela,Howard Kenneth A.,Davies Jane C.,Petersen Eskild,Vorup-Jensen Thomas

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-15969-3.pdf

Reference54 articles.

1. Giske, C. G., Monnet, D. L., Cars, O. & Carmeli, Y. ReAct-Action on Antibiotic, R. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52, 813–821, https://doi.org/10.1128/AAC.01169-07 (2008).

2. Bush, K. Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check. Acs Infect Dis 1, 509–511, https://doi.org/10.1021/acsinfecdis.5b00100 (2015).

3. Sancho-Vaello, E. & Zeth, K. Antimicrobial peptides: has their time arrived? Future Microbiol 10, 1103–1106, https://doi.org/10.2217/fmb.15.45 (2015).

4. Haney, E. F. & Hancock, R. E. Peptide design for antimicrobial and immunomodulatory applications. Biopolymers 100, 572–583, https://doi.org/10.1002/bip.22250 (2013).

5. Marr, A. K., Gooderham, W. J. & Hancock, R. E. W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Current Opinion in Pharmacology 6, 468–472, https://doi.org/10.1016/j.coph.2006.04.006 (2006).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An escape from ESKAPE pathogens: A comprehensive review on current and emerging therapeutics against antibiotic resistance;International Journal of Biological Macromolecules;2024-11

2. Antimicrobial peptide glatiramer acetate targets Pseudomonas aeruginosa lipopolysaccharides to breach membranes without altering lipopolysaccharide modification;npj Antimicrobials and Resistance;2024-02-20

3. Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation;Neurologic Clinics;2024-02

4. Drug repurposing for fungal infections;Progress in Molecular Biology and Translational Science;2024

5. Impact of Disease-Modifying Therapies on Gut–Brain Axis in Multiple Sclerosis;Medicina;2023-12-20